Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Pharm. 2013 Aug 16;452(1-2):266-9. doi: 10.1016/j.ijpharm.2013.05.032. Epub 2013 May 21.

Controlled release of morphine from a poloxamer 407 gel.

Author information

  • 1Midden-Brabant Hospital Pharmacy, TweeSteden Hospital and St. Elisabeth Hospital, Tilburg, The Netherlands. mjansen@tsz.nl

Abstract

Treatment of painful ulcers is discouraging. Topical morphine has been described as a useful therapeutic adjunct in some patients. In the development of a new analgesic product, we studied the in vitro release characteristics of a new topical formulation containing 0.5% (w/w) morphine-HCl in a poloxamer 407 (P407) based gel. A diffusion cell was used for measurement of in vitro release characteristics. The donor compartment (DC) and the receptor compartment (RC) were separated by a 5000 Da cellulose acetate membrane. The morphine-HCl release from this developed P407 based gel followed zero-order kinetics with a constant release of 150 μg cm(-2)h(-1). Our results support the use of this P407 gel as a sustained release topical formulation in the pharmacological treatment of painful ulcers. Future research welcomes a formulation with release characteristics leading to less frequent application.

Copyright © 2013 Elsevier B.V. All rights reserved.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk